MY ACCOUNT | NEWSLETTER |

Petriage wins patent for triage technology


Petriage wins patent for triage technology

Veterinary telehealth provider, Petriage, has secured a patent for its teletriage system. The new patented platform offers its services to pets and people. 

With the new patent, Petriage is planning to continue to develop is AI-based technologies, including triage and symptom analysis solutions. One of the goals in such development will be to expand the technologies to include human healthcare. 

Like the existing triage system for pets, the technology would include a tool to remotely monitor patients, to connect patients for virtual appointments, and to analyze symptoms to pinpoint disease with information on how urgent seeking treatment would be. 

"Our original impetus was to empower vets like me and provide their clients with peace of mind by leveraging AI to deliver remote patient care," said Dr. Allon Freiman, co-founder of Petriage and co-developer of the algorithm driving the technology. "But the 97%-plus accuracy of the AI-driven symptom analysis tool has exceeded what we initially envisioned."

The business-to-business pet health technology firm was awarded patent number 11355249, which is set to be issued on June 7th. The patent is the second for the company after it received an initial patent for a pet symptom analysis tool that works remotely. 


Like0
Dislike1
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Penn Vet Announces Interim Leadership for the Department of Clinical Sciences and Advanced Medicine, and Ryan Hospital

Like0
Dislike0

Parnell Launches nixiFLOR® - First FDA-Approved Generic Florfenicol + Flunixin Combination for BRD

Like0
Dislike0

Comparison of two host cell range variants of feline immunodeficiency virus

Like0
Dislike0

Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment

Like0
Dislike0

The use of growth promoters in swine nutrition: Problems and perspectives concerning public health and swine production

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top